FREDERICK, Md., Aug. 18, 2014 /PRNewswire/ -- BioElectronics
Corporation (OTC Pink: BIEL), the maker of advanced consumer
medical devices said that its EVP Dr. Deepak Kotak was interviewed by CEOLIVE.TV as
part of its Executive Interview Series.
The entire interview is available at
http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel
In the interview Dr. Kotak explains to investors the unique
advantages of BioElectronics patented technology to satisfy the
unmet medical needs of millions of consumers. He explains how
the Company is positioned to serve new, large medical markets with
its drug-free, non-invasive technology.
Before joining BioElectronics Dr. Kotak was Chief Medical
Officer of TraumaTec, a Houston
medical device company, as well as a consultant to the Boss Group
and Blackstone Valley Group, two private equity firms.
Dr. Kotak brings a broad medical background and health care
perspective to the Company, having practiced as a specialist in
intensive care medicine, anesthesia and trauma in a London teaching hospital. Dr. Kotak has also
practiced for four years as a civil lawyer. Dr. Kotak holds degrees
in medicine from Oxford University and
the University of London.
About CEOLIVE.TV
CEOLIVE.TV is an online financial news portal focused on small
cap publicly traded companies with a focus on undervalued stocks.
Featuring short video interviews with CEOs, CFOs, Board Members and
other corporate executives, CEOLIVE.TV gives investors the
opportunity to learn about companies directly from the management
team as well as access to detailed company profiles, video press
releases and sector reports. To learn more, please visit
www.ceolive.tv.
About BioElectronics Corporation
BioElectronics
Corporation is a leader in biophysics and the maker of an industry
leading family of disposable, drug-free, pain therapy devices:
ActiPatch® Therapy, over-the-counter treatment for back
pain and other musculoskeletal complaints; RecoveryRx®
Devices for chronic and post-operative wound care;
Allay® Menstrual Pain Therapy; and HealFast®
Therapy for dogs, cats and horses. For more information,
please visit www.bielcorp.com.
Forward Looking Statements
Certain information contained in this press release, including
any information as to our strategy, plans or future financial or
operating performance and other statements that express
management's expectations or estimates of future performance,
constitute "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Action of 1934. All statements, other than
statements of historical fact, are forward-looking statements. The
words "believe," "expect," "will," "anticipate," "contemplate,"
"target," "plan," "continue," "budget," "may," "intend,"
"estimate," "project" and similar expressions identify
forward-looking statements. Forward-looking statements are subject
to risks and uncertainties that could cause actual results to
differ materially from those expressed in the forward-looking
statements, including, but not limited to, certain delays beyond
the company's control with respect to its plans or operations. Our
actual results may differ materially from the results anticipated
in these forward-looking statements due to a variety of factors,
including, without limitation those set forth as "Risk Factors" in
our filings with the SEC which can be found at www.sec.gov. There
may be other factors not mentioned above or included in the
Company's SEC filings that may cause actual results to differ
materially from those projected in any forward-looking statement.
The Company disclaims any intention or obligation to update or
revise any forward-looking statements whether as a result of new
information, future events or otherwise, except as required by
applicable law.
For Investor and Media Inquiries, please contact:
BioElectronics Corporation Investor Relations
E and E Communications
Paul Knopick
Email: pknopick@eandecommunications.com
Tel 940.262.3584
SOURCE BioElectronics Corporation
